Japan PMDA To Kick Off New Asia Training Center
This article was originally published in PharmAsia News
Executive Summary
Japan's regulatory body will set up a new center next month to help in the training of other drug and device authorities across Asia, as part of its growing international activities.
You may also be interested in...
Oncology Dominates Japan Approvals, Though Overall Tally Is Lower
Although it approved fewer new products last fiscal year, Japan granted access to a number of important new therapies, including in oncology and several for the first time worldwide, helped by continuing reforms at its regulatory body.
Japan Builds Asia Links Through New AMED Programs
In line with similar initiatives by Japan on other regulatory fronts, the country's Agency for Medical Research and Development is building up its partnerships and presence in Asia.
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: another big deal in radiopharmaceuticals; BioNTech’s ADC pipeline; China CDMOs embrace uncertain future; at look at the rivals in MASH; and industry views on how AI might be transformative.